2023
Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis
Safiriyu I, Mehta A, Adefuye M, Nagraj S, Kharawala A, Hajra A, Shamaki G, Kokkinidis D, Bob-Manuel T. Incidence and Prognostic Implications of Cardiac-Implantable Device-Associated Tricuspid Regurgitation: A Meta-Analysis and Meta-Regression Analysis. The American Journal Of Cardiology 2023, 209: 203-211. PMID: 37863117, DOI: 10.1016/j.amjcard.2023.09.064.Peer-Reviewed Original ResearchConceptsCardiac implantable electronic devicesTricuspid regurgitationMeta-regression analysisHF hospitalizationCause mortalityPrognostic implicationsEligible studiesComposite of mortalityHeart failure hospitalizationVentricular ejection fractionElectronic databases MEDLINEMeta-Analyses (PRISMA) guidelinesPreferred Reporting ItemsRandom-effects modelFinal quantitative analysisWeb of ScienceCardiac implantable devicesImplantable electronic devicesFailure hospitalizationMean followEjection fractionDevice implantationTrue incidenceMean ageOdds ratioComparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females.
Alhuarrat MAD, Pargaonkar S, Rahgozar K, Safiriyu I, Zhang X, Faillace RT, Di Biase L. Comparison of in-hospital outcomes and complications of left atrial appendage closure with the Watchman device between males and females. Europace 2023, 25 PMID: 37503957, DOI: 10.1093/europace/euad228.Peer-Reviewed Original ResearchRecent Advances and Future Prospects of Treatment of Pulmonary Hypertension.
Hajra A, Safiriyu I, Balasubramanian P, Gupta R, Chowdhury S, Prasad AJ, Kumar A, Kumar D, Khan B, Bilberry RSF, Sarkar A, Malik P, Aronow WS. Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension. Curr Probl Cardiol 2023, 48: 101236. PMID: 35500734, DOI: 10.1016/j.cpcardiol.2022.101236.Peer-Reviewed Original ResearchThirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure.
Fatuyi M, Udongwo N, Favour M, Alshami A, Sanyi A, Amah C, Safiriyu I, Al-Amoodi M, Sealove B, Shishehbor MH, Shemisa K. Thirty-Day Readmission Rate and Healthcare Economic Effects of Patients With Transcatheter Aortic Valve Replacement and Coexisting Chronic Congestive Heart Failure. Curr Probl Cardiol 2023, 48: 101695. PMID: 36921650, DOI: 10.1016/j.cpcardiol.2023.101695.Peer-Reviewed Original ResearchImpact of COVID-19 Infection on the Clinical Outcomes of Pulmonary Embolism Hospitalizations : A Nationwide Analysis.
Safiriyu I, Fatuyi M, Mehta A, Naser A, Alexander E, Vovan H, Shamaki GR, Bob-Manuel T. Impact of COVID-19 Infection on the Clinical Outcomes of Pulmonary Embolism Hospitalizations : A Nationwide Analysis. Curr Probl Cardiol 2023, 48: 101669. PMID: 36841316, DOI: 10.1016/j.cpcardiol.2023.101669.Peer-Reviewed Original ResearchTranscatheter edge-to-edge repair of the mitral valve in end stage renal disease patients: mortality fact check.
Safiriyu I, Nagraj S. Transcatheter edge-to-edge repair of the mitral valve in end stage renal disease patients: mortality fact check. Ann Transl Med 2023, 11: 305. PMID: 37404987, DOI: 10.21037/atm-23-1363.Peer-Reviewed Original ResearchIncidence, predictors and outcomes of new onset systolic heart failure following orthotopic liver transplant: A systematic review.
Kharawala A, Safiriyu I, Olayinka A, Hajra A, Seo J, Akunor H, Alhuarrat MAD, Thachil R. Incidence, predictors and outcomes of new onset systolic heart failure following orthotopic liver transplant: A systematic review. Transplant Rev (Orlando) 2023, 37: 100758. PMID: 37027999, DOI: 10.1016/j.trre.2023.100758.Peer-Reviewed Original ResearchPresent Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article.
Biswas S, Bahar Y, Bahar AR, Safiriyu I, Mathai SV, Hajra A, Gupta R, Aronow WS. Present Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article. Curr Probl Cardiol 2023, 48: 101483. PMID: 36336118, DOI: 10.1016/j.cpcardiol.2022.101483.Peer-Reviewed Original Research
2022
A Meta-Analysis on the Impact of High BMI in Patients Undergoing Transcatheter Aortic Valve Replacement
Seo J, Li W, Safiriyu I, Kharawala A, Nagraj S, Tahir A, Doundoulakis I, Koliastasis L, Rios S, Palaiodimos L, Kokkinidis D. A Meta-Analysis on the Impact of High BMI in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal Of Cardiovascular Development And Disease 2022, 9: 386. PMID: 36354785, PMCID: PMC9695436, DOI: 10.3390/jcdd9110386.Peer-Reviewed Original ResearchBody mass indexNormal body mass indexMajor vascular complicationsShort-term mortalityLower riskTerm mortalityVascular complicationsHazard ratioOdds ratio/relative riskTranscatheter Aortic Valve Replacement OutcomesRatio/relative riskTranscatheter aortic valve replacementHigher body mass indexAortic valve replacementPermanent pacemaker implantationDifferent BMI groupsLower mortality riskHigher likelihoodTAVR outcomesValve replacementPacemaker implantationBMI groupsMass indexPermanent pacemakerTerm outcomesPrevalence and Outcomes in STEMI Patients Without Standard Modifiable Cardiovascular Risk Factors: A National Inpatient Sample Analysis.
Shamaki GR, Safiriyu I, Kesiena O, Mbachi C, Anyanwu M, Zahid S, Rai D, Bob-Manuel T, Corteville D, Alweis R, Batchelor WB. Prevalence and Outcomes in STEMI Patients Without Standard Modifiable Cardiovascular Risk Factors: A National Inpatient Sample Analysis. Curr Probl Cardiol 2022, 47: 101343. PMID: 35934021, DOI: 10.1016/j.cpcardiol.2022.101343.Peer-Reviewed Original ResearchAssessment of 2-Year Mortality With Use of Drug-Coated Devices in Femoropopliteal Disease: A Real-World Experience From the Bronx, New York.
Safiriyu I, Gumber D, Palaiodimos L, Sokol S, Mathai SV, Shah A, Rivera A, Karamanis D, Kakkar A. Assessment of 2-Year Mortality With Use of Drug-Coated Devices in Femoropopliteal Disease: A Real-World Experience From the Bronx, New York. Cardiovasc Revasc Med 2022, 41: 99-104. PMID: 35058158, DOI: 10.1016/j.carrev.2022.01.009.Peer-Reviewed Original ResearchPrognostic Impact of Pre- and Post-Procedural Renal Dysfunction on Late All-Cause Mortality Outcome Following Transcatheter Edge-to-Edge Repair of the Mitral Valve: A Systematic Review and Meta-Analysis
Safiriyu I, Nagraj S, Otulana R, Saralidze T, Kokkinidis D, Faillace R. Prognostic Impact of Pre- and Post-Procedural Renal Dysfunction on Late All-Cause Mortality Outcome Following Transcatheter Edge-to-Edge Repair of the Mitral Valve: A Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine 2022, 42: 6-14. PMID: 35398011, DOI: 10.1016/j.carrev.2022.03.023.Peer-Reviewed Original ResearchConceptsChronic kidney diseaseCause mortalityRenal dysfunctionTranscatheter edgeSystematic reviewEdge mitral valve repairSevere heart failureStrong independent predictorMitral valve repairMeta-Analyses (PRISMA) guidelinesElectronic databases PubMedPreferred Reporting ItemsRandom-effects modelWeb of ScienceMitraClip implantationPeriprocedural planningCKD severityRenal functionHeart failureIndependent predictorsPrognostic impactValve repairAdverse outcomesKidney diseaseEdge repair